Axitinib
Related papers: 4
Top Researchers
Bernard Escudier
Institution: —
Jean‐Alexandre Long
Institution: —
Jean‐Christophe Bernhard
Institution: —
Idir Ouzaïd
Institution: —
Pierre Bigot
Institution: —
Arnaud Méjean
Institution: —
Jean‐Jacques Patard
Institution: —
Karim Bensalah
Institution: —
R. Sherburne Figenshau
Institution: —
Adeel Khan
Institution: —
Top Cited Papers
Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : prise en charge du cancer du rein
Karim Bensalah, Pierre Bigot, Laurence Albigès, Jean‐Christophe Bernhard, Thomas Bodin, R. Boissier, Jean-Michel Corréas, P. Gimel, Jean François Hetet, Jean‐Alexandre Long, F. Nouhaud, Idir Ouzaïd, Arnaud Méjean
Citations: 24 • 2020
Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma
Melissa A. Reimers, R. Sherburne Figenshau, Eric H. Kim, Julie Tucker, Nicole Kasten, Adeel Khan, Jan M. Hanneken, Zachary L. Smith, James J. Hsieh
Citations: 19 • 2020
Phase II study of axitinib for downstaging cT2a to cT1 renal tumors for allowing partial nephrectomy (AXIPAN).
Jean‐Jacques Patard, J. Bernard, Karim Bensalah, Hervé Baumert, Hervé Lang, Didier Jacqmin, Brigitte Duclos, Alain Ravaud, Brigitte Laguerre, Laurence Albigès, Armelle Arnoux, Bernard Escudier
Citations: 2 • 2016
A case report of robot-assisted radical nephrectomy and inferior vena cava thrombectomy in a patient with renal cell carcinoma after pembrolizumab and axitinib combination therapy
Ryo Shiode, Terutaka Noda, Shota Nobumori, Naoya Sugihara, Maki Yamakawa, Kaori Saiki, Takatora Sawada, Reina Kono, Toshio Kakuda, Kenichi Nishimura, Tetsuya Fukumoto, Noriyoshi Miura, Tadahiko Kikugawa, Takashi Saika
Citations: 1 • 2024